{
    "title": "Outside advisory panel urges the FDA NOT to approve Biogen's Alzheimer's drug, dimming hopes for the first new treatment in nearly 20 years",
    "url": "https://www.dailymail.co.uk/health/article-8920341/FDA-panel-reviews-1st-new-Alzheimers-drug-2-decades.html",
    "date": "2020-11-06",
    "keywords": [
        "drug",
        "study",
        "fda",
        "biogen",
        "panel",
        "aducanumab",
        "evidence",
        "safety",
        "brain",
        "health",
        "analysis",
        "medicine",
        "rate",
        "decline",
        "dose",
        "care",
        "cost",
        "meeting",
        "food",
        "administration",
        "benefit",
        "cambridge",
        "week",
        "dr",
        "university",
        "decision",
        "march",
        "research",
        "claim",
        "review",
        "share",
        "system",
        "group",
        "effectiveness",
        "approval",
        "protein",
        "difference",
        "medicare",
        "family",
        "masliah",
        "agency",
        "thee",
        "braindestroying",
        "skepticism",
        "conclusion",
        "treatment",
        "urgent",
        "need",
        "joel",
        "perlmutter",
        "washington",
        "school",
        "something",
        "risk",
        "treatmentshe",
        "drugthe",
        "guidance",
        "opinion",
        "dec",
        "photo",
        "scientist",
        "laboratory",
        "mass",
        "inc",
        "david",
        "whitebiogen",
        "commentary",
        "rejection",
        "viewpoint",
        "day",
        "fdas",
        "staff",
        "reviewer",
        "issuesit",
        "audio",
        "video",
        "tv",
        "sync",
        "member",
        "caleb",
        "alexander",
        "johns",
        "article",
        "year",
        "course",
        "form",
        "consumer",
        "citizen",
        "meetingthe",
        "evaluation",
        "association",
        "part",
        "addyoocanyoomab",
        "betaamyloid",
        "tau",
        "toxic",
        "ability",
        "biotech",
        "price",
        "estimate"
    ],
    "category": [
        "health"
    ]
}